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Introduction {#jah31490-sec-0004}
============

Over 5.7 million persons in the United States and at least 23 million people worldwide live with heart failure (HF),[1](#jah31490-bib-0001){ref-type="ref"}, [2](#jah31490-bib-0002){ref-type="ref"}, [3](#jah31490-bib-0003){ref-type="ref"} which is associated with considerable morbidity, mortality, and health care costs. Cardiovascular disease remains the leading cause of death in the United States.[4](#jah31490-bib-0004){ref-type="ref"}, [5](#jah31490-bib-0005){ref-type="ref"} Mortality rates among HF patients, in particular, are high. Of all deaths in the United States in 2009 (from any cause), 11% listed HF as a cause or contributing factor.[6](#jah31490-bib-0006){ref-type="ref"} HF hospitalization rates also remain high, with over 1 million hospital discharges for HF in 2010, a rate essentially unchanged since 2000.[3](#jah31490-bib-0003){ref-type="ref"}, [7](#jah31490-bib-0007){ref-type="ref"} Whereas HF is often considered a problem of the elderly, the rate of hospitalizations for HF patients under age 65 has significantly increased as well,[8](#jah31490-bib-0008){ref-type="ref"} and despite efforts to prevent or delay the onset of cardiovascular disease, the prevalence of HF continues to rise.[2](#jah31490-bib-0002){ref-type="ref"}, [3](#jah31490-bib-0003){ref-type="ref"}

HF patients are taught self‐care strategies to help manage symptoms, maintain physical functioning, and prevent symptom exacerbations and worsening of disease that could lead to hospitalization or death. Medication is a critical part of HF treatment, and adhering to medication regimens is a key behavior in HF self‐care. Unfortunately, adherence among patients with HF is low, negatively affecting clinical outcomes and leading to increased HF exacerbations, reduced physical function, and higher risk for hospital admission and death.[9](#jah31490-bib-0009){ref-type="ref"}, [10](#jah31490-bib-0010){ref-type="ref"}, [11](#jah31490-bib-0011){ref-type="ref"}

Many interventions have been tested to improve adherence to medication among HF patients, but the overall impact of these interventions on patient mortality and hospital readmissions is not known. Previous reviews have only synthesized very few studies and may not accurately reflect the overall state of the literature. This article reports the results of a comprehensive systematic review and meta‐analysis of mortality and hospitalization outcomes from HF medication adherence (MA) intervention studies.

Methods {#jah31490-sec-0005}
=======

This research synthesis used well‐established systematic review the and meta‐analysis methods, with reporting according to Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines.[12](#jah31490-bib-0012){ref-type="ref"}, [13](#jah31490-bib-0013){ref-type="ref"}, [14](#jah31490-bib-0014){ref-type="ref"} The project protocol is available from the primary author upon request.

Study Eligibility {#jah31490-sec-0006}
-----------------

Studies of adults (age ≥18 years) testing interventions to improve adherence to medications among patients with a diagnosis of HF were eligible for inclusion in the meta‐analysis. Studies of patients who were institutionalized or otherwise not involved with administering their own medications were excluded. Both published and unpublished studies were included in order to analyze as comprehensive a sample of studies as possible. Searches were not limited by language; potentially eligible studies warranting further review were translated into English as necessary. Studies were not initially excluded based on study design or any a priori measure of study quality. In meta‐analyses, two‐group studies are analyzed separately from any single‐group (pre‐post) studies. Only 1 single‐group study met the eligibility and outcome criteria for this project. As a result, this analysis focuses only on those studies with 2‐group (ie, intervention vs control) comparisons.

Search Strategies and Information Sources {#jah31490-sec-0007}
-----------------------------------------

Multiple search strategies were employed to identify as many eligible studies as possible. Electronic database searches were developed and carried out by a health sciences research librarian on the research team. Databases searched included MEDLINE, CINAHL, PsycINFO, Cochrane Central Register of Controlled Trials, Scopus, ProQuest, International Pharmaceutical Abstracts, DARE, and Highwire. All databases were searched from inception through 2013. Search terms were developed for each database, including both indexed search terms (eg, MeSH terms) and free‐text keywords. For example, the MeSH and free text keyword search terms included medication adherence, patient compliance, adherent, adherence, non‐compliant, noncompliance, nonadherent, nonadherence, prescription drugs, dosage forms, generic, prescription(s), prescribed, drug(s), medications, pill(s), tablet(s), regimen(s), improve, promote, enhance, encourage, foster, advocate, influence, incentive, ensure, remind, optimize, increase, impact, address, decrease, heart failure, congestive heart failure, CHF, and HF. See Table [1](#jah31490-tbl-0001){ref-type="table-wrap"} for a sample search strategy.

###### 

Search Strategy for Medline

  ------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1\.    patient compliance/
  2\.    medication adherence/
  3\.    1 or 2
  4\.    exp Vaccines/
  5\.    immunization/or immunization schedule/or immunotherapy, active/or vaccination/or mass vaccination/
  6\.    exp Contraceptive Agents/
  7\.    Contraception Behavior/
  8\.    exp Contraception/
  9\.    (viagra or sildenafil).mp.
  10\.   exp antipsychotic agents/
  11\.   exp Mental Retardation/
  12\.   exp "schizophrenia and disorders with psychotic features"/
  13\.   exp Substance‐Related Disorders/
  14\.   Mental Disorders/
  15\.   exp Psychiatry/
  16\.   Probiotics/
  17\.   disabled children/or mentally disabled persons/or mentally ill persons/
  18\.   Prisoners/
  19\.   group homes/or exp nursing homes/
  20\.   Institutionalization/
  21\.   Military Personnel/
  22\.   Disulfiram/
  23\.   antabuse.mp.
  24\.   exp Methadone/
  25\.   or/5‐24
  26\.   ((improv\$ or promot\$ or enhanc\$ or encourag\$ or foster\$ or advocat\$ or influenc\$ or incentiv\$ or ensur\$ or remind\$ or optimiz\$ or optimis\$ or increas\$ or impact\$) adj5 (complian\$ or adheren\$)).mp.
  27\.   ((prevent\$ or address\$ or decreas\$) adj5 (noncomplian\$ or nonadher\$ or non complian\$ or non adher\$)).mp.
  28\.   3 not 25
  29\.   (medicat\$ or regimen\$ or prescription\$ or prescribed or drug\$ or pill or pills or tablet\$ or chemotherap\$).mp.
  30\.   dt.fs.
  31\.   pharmaceutical preparations/or exp dosage forms/or drugs, generic/or prescription drugs/
  32\.   agents.hw.
  33\.   meds.tw.
  34\.   (regimen or regimens).tw.
  35\.   or/29‐34
  36\.   28 and 35
  37\.   \*patient compliance/
  38\.   (complian\$ or adher\$ or noncomplian\$ or nonadher).ti.
  39\.   (complian\$ or adher\$).ab. /freq=2
  40\.   26 or 27 or 37 or 38 or 39
  41\.   exp heart failure
  42\.   (CHF or HF or heart failure).af.
  43\.   cardiac.mp.
  44\.   41 or 42 or 43
  45\.   36 or 40
  46\.   44 and 45
  ------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Further search methods included hand searching of selected journals for the previous 10 years to identify studies that may not have been located through electronic database searching. Reference lists of review articles were searched to identify further studies, and author searches were conducted on the names of primary investigators of eligible studies. Research registries, such as [clinicaltrials.gov](http://clinicaltrials.gov), and conference proceedings were also searched to identify studies that had been conducted but not reported in an indexed source.

Each search result was evaluated for eligibility by 2 research staff. The full text of any studies deemed potentially eligible in the initial screening were evaluated to determine final eligibility. Every eligible study was independently coded and entered into separate databases by 2 trained research staff. Data were compared to reach 100% agreement on all coding items to ensure data accuracy. If a study report did not include sufficient data for calculating an effect size (ES), the study authors were contacted and asked to provide the necessary information.

Risk of Bias {#jah31490-sec-0008}
------------

Studies were not evaluated a priori for study quality or risk of bias, because no validated tools for this exist and require subjective evaluation by evaluators. Rather, the research team coded study characteristics that are typically considered to be quality indicators (eg, randomization, use of intention‐to‐treat, blinding of data collectors, study attrition, etc) and analyzed them empirically by moderator analyses. In this way, rather than excluding studies for perceived methodological flaws, we could determine whether indicators of risk for bias actually affected ES.

Statistical Analyses {#jah31490-sec-0009}
--------------------

Analyses were performed using Comprehensive Meta‐Analysis software (Biostat, Inc., Englewood, NJ). A relative risk (RR) ES was calculated for each study reporting mortality outcomes. Whereas we are reporting RR for hospitalization outcomes, not all studies provided sufficient data for calculating RR, but all studies did report sufficient data for calculating an odds ratio (OR). Therefore, we are reporting both RR and OR ES measures for hospitalization outcomes.

For studies testing more than 1 intervention and sharing the same control group, we followed procedures established by the Cochrane Collaboration as well as Borenstein, Cooper, and colleagues by merging intervention groups to avoid dependency among comparisons in the meta‐analysis.[13](#jah31490-bib-0013){ref-type="ref"}, [14](#jah31490-bib-0014){ref-type="ref"}, [15](#jah31490-bib-0015){ref-type="ref"}

Study ESs were pooled using a random‐effects model. The random‐effects model was chosen because of the expected heterogeneity across samples and across studies testing different types of adherence interventions. Substantial heterogeneity is expected in health behavior research. Each individual study ES was weighted by the inverse of its total variance (the study\'s sampling variance plus the calculated between‐study variance, or *Τ* ^2^). Studies with significant standardized residuals were examined as potential outliers. Heterogeneity across the studies was assessed using the heterogeneity statistic, *Q*, as well as *I* ^2^, which is a "signal‐to‐noise" ratio indicating the proportion of between‐study heterogeneity in the meta‐analysis. We assessed for publication bias by visual examination of funnel plots (see Figures [1](#jah31490-fig-0001){ref-type="fig"} and [2](#jah31490-fig-0002){ref-type="fig"}).

![Funnel plot for mortality outcomes.](JAH3-5-e002606-g001){#jah31490-fig-0001}

![Funnel plot for readmission outcomes.](JAH3-5-e002606-g002){#jah31490-fig-0002}

Moderator analyses were conducted for potential moderator variables that were present in a sufficient number of studies to further explain heterogeneity across studies, compare effects between different subgroups, and evaluate the impact of potential sources of bias. We used metaregression for continuous variables and a meta‐analytic analogue of ANOVA for categorical variables. Moderator analyses were conducted on study characteristics (such as year of publication or whether a study reported a funding source), sample characteristics (mean age, sex, and race/ethnicity), and intervention characteristics.

Results {#jah31490-sec-0010}
=======

Literature searching resulted in 6665 citations of potentially eligible studies. Of those, 234 were screened as being eligible for full‐text review, and 57 studies fulfilled the inclusion criteria for this meta‐analysis (see Figure [3](#jah31490-fig-0003){ref-type="fig"}). Mortality outcomes were reported for 48 studies. Hospitalization/readmission outcomes were reported for 43 studies.

![Flow diagram of study selection. s=number of studies. HF indicates heart failure; MA, medication adherence.](JAH3-5-e002606-g003){#jah31490-fig-0003}

Primary Study Characteristics {#jah31490-sec-0011}
-----------------------------

Studies in the sample were published between 1996 and 2013. Attributes for each study are reported in Table [2](#jah31490-tbl-0002){ref-type="table-wrap"},[16](#jah31490-bib-0016){ref-type="ref"}, [17](#jah31490-bib-0017){ref-type="ref"}, [18](#jah31490-bib-0018){ref-type="ref"}, [19](#jah31490-bib-0019){ref-type="ref"}, [20](#jah31490-bib-0020){ref-type="ref"}, [21](#jah31490-bib-0021){ref-type="ref"}, [22](#jah31490-bib-0022){ref-type="ref"}, [23](#jah31490-bib-0023){ref-type="ref"}, [24](#jah31490-bib-0024){ref-type="ref"}, [25](#jah31490-bib-0025){ref-type="ref"}, [26](#jah31490-bib-0026){ref-type="ref"}, [27](#jah31490-bib-0027){ref-type="ref"}, [28](#jah31490-bib-0028){ref-type="ref"}, [29](#jah31490-bib-0029){ref-type="ref"}, [30](#jah31490-bib-0030){ref-type="ref"}, [31](#jah31490-bib-0031){ref-type="ref"}, [32](#jah31490-bib-0032){ref-type="ref"}, [33](#jah31490-bib-0033){ref-type="ref"}, [34](#jah31490-bib-0034){ref-type="ref"}, [35](#jah31490-bib-0035){ref-type="ref"}, [36](#jah31490-bib-0036){ref-type="ref"}, [37](#jah31490-bib-0037){ref-type="ref"}, [38](#jah31490-bib-0038){ref-type="ref"}, [39](#jah31490-bib-0039){ref-type="ref"}, [40](#jah31490-bib-0040){ref-type="ref"}, [41](#jah31490-bib-0041){ref-type="ref"}, [42](#jah31490-bib-0042){ref-type="ref"}, [43](#jah31490-bib-0043){ref-type="ref"}, [44](#jah31490-bib-0044){ref-type="ref"}, [45](#jah31490-bib-0045){ref-type="ref"}, [46](#jah31490-bib-0046){ref-type="ref"}, [47](#jah31490-bib-0047){ref-type="ref"}, [48](#jah31490-bib-0048){ref-type="ref"}, [49](#jah31490-bib-0049){ref-type="ref"}, [50](#jah31490-bib-0050){ref-type="ref"}, [51](#jah31490-bib-0051){ref-type="ref"}, [52](#jah31490-bib-0052){ref-type="ref"}, [53](#jah31490-bib-0053){ref-type="ref"}, [54](#jah31490-bib-0054){ref-type="ref"}, [55](#jah31490-bib-0055){ref-type="ref"}, [56](#jah31490-bib-0056){ref-type="ref"}, [57](#jah31490-bib-0057){ref-type="ref"}, [58](#jah31490-bib-0058){ref-type="ref"}, [59](#jah31490-bib-0059){ref-type="ref"}, [60](#jah31490-bib-0060){ref-type="ref"}, [61](#jah31490-bib-0061){ref-type="ref"}, [62](#jah31490-bib-0062){ref-type="ref"}, [63](#jah31490-bib-0063){ref-type="ref"}, [64](#jah31490-bib-0064){ref-type="ref"}, [65](#jah31490-bib-0065){ref-type="ref"}, [66](#jah31490-bib-0066){ref-type="ref"}, [67](#jah31490-bib-0067){ref-type="ref"}, [68](#jah31490-bib-0068){ref-type="ref"}, [69](#jah31490-bib-0069){ref-type="ref"}, [70](#jah31490-bib-0070){ref-type="ref"}, [71](#jah31490-bib-0071){ref-type="ref"}, [72](#jah31490-bib-0072){ref-type="ref"} and study demographics are summarized in Table [3](#jah31490-tbl-0003){ref-type="table-wrap"}. Study participants were largely older, with mean sample ages ranging from 45 to 80 years (median, 70.4). Information on type of HF was inconsistently reported in the primary studies. In those studies that did report the type of HF, the sample consisted entirely or predominantly of patients with reduced ejection fraction. Studies had a median sample size of 197. Whereas many of the studies reported some degree of attrition between randomization and final follow‐up, all but 3 reported mortality and/or hospitalization outcomes for all randomized subjects, even if other measures were not collected for subjects lost to follow‐up.[62](#jah31490-bib-0062){ref-type="ref"}, [63](#jah31490-bib-0063){ref-type="ref"}, [70](#jah31490-bib-0070){ref-type="ref"}

###### 

Characteristics of Heart Failure Medication Adherence Trials Reporting Mortality or Readmission Outcomes

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study (Year)                                                                                                 Country                                                                                                                                                                                                                                                                                          NYHA Class, %[a](#jah31490-note-0002){ref-type="fn"} Mean LVEF, %   Mean Age, yr % Female   No. of Subjects Randomized   Data Collectors Blinded   Outcomes
  ------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------- ----------------------- ---------------------------- ------------------------- ----------------------
  Antonicelli (2008, 2010)[16](#jah31490-bib-0016){ref-type="ref"}, [17](#jah31490-bib-0017){ref-type="ref"}   Italy                                                                                                                                                                                                                                                                                            NR/58/37/5\                                                         78\                     Tx: 28\                      NR                        Mortality RR: 0.58\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 36%                                                           39%                     Co: 29                                                 Readmission OR: 0.04

  Intervention:                                                                                                Weekly telemonitoring assessing adherence and HF symptoms, adjusting treatment as needed                                                                                                                                                                                                                                                                                                                                                            

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Assyag (2009)[18](#jah31490-bib-0018){ref-type="ref"}                                                        France                                                                                                                                                                                                                                                                                           NR/NR/44/55\                                                        72.9\                   Tx: 218\                     NR                        Mortality RR: 0.86\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            41.7%                   Co: 211                                                Readmission OR: 1.17

  Intervention:                                                                                                Multidisciplinary HF management and patient education, and symptom monitoring                                                                                                                                                                                                                                                                                                                                                                       

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Atienza (2004)[19](#jah31490-bib-0019){ref-type="ref"}                                                       Spain                                                                                                                                                                                                                                                                                            10.5/39.5/40/10\                                                    68\                     Tx: 164\                     NR                        Mortality RR: 0.62\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 36%[b](#jah31490-note-0003){ref-type="fn"}                    40%                     Co: 174                                                Readmission OR: 0.51

  Intervention:                                                                                                Inpatient education about HF, self‐monitoring, and medications; Postdischarge clinic follow‐up and telemonitoring                                                                                                                                                                                                                                                                                                                                   

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Azad (2008)[20](#jah31490-bib-0020){ref-type="ref"}                                                          Canada                                                                                                                                                                                                                                                                                           25/45/27/NR\                                                        75\                     Tx: 45\                      Y                         Mortality RR: 0.21\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            100%                    Co: 46                                                 Readmission OR: NR

  Intervention:                                                                                                Multidisciplinary HF clinical pathway program (12 visits over 6 weeks) including education and counseling                                                                                                                                                                                                                                                                                                                                           

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Balk (2008)[21](#jah31490-bib-0021){ref-type="ref"}                                                          Netherlands                                                                                                                                                                                                                                                                                      7/40/48/2\                                                          66\                     Tx: 101\                     NR                        Mortality RR: 1.25\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 31%                                                           30%                     Co: 113                                                Readmission OR: NR

  Intervention:                                                                                                Video‐based patient education, adherence reminders, and motivational messages                                                                                                                                                                                                                                                                                                                                                                       

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Bisharat (2012)[22](#jah31490-bib-0022){ref-type="ref"}                                                      Israel                                                                                                                                                                                                                                                                                           NR                                                                  69.4\                   Tx: 33\                      NR                        Mortality RR: NR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    32.4%                   Co: 41                                                 Readmission OR: 0.68

  Intervention:                                                                                                Patient counseling by nurse (predischarge) and pharmacist (postdischarge)                                                                                                                                                                                                                                                                                                                                                                           

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Blue (2001)[23](#jah31490-bib-0023){ref-type="ref"}                                                          UK                                                                                                                                                                                                                                                                                               NR/21.5/38/40.5\                                                    75\                     Tx: 84\                      Y                         Mortality RR: 0.96\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            42%                     Co: 81                                                 Readmission OR: 0.83

  Intervention:                                                                                                Nursing home visits and telephone contacts for medication and disease education, self‐monitoring, and psychological support                                                                                                                                                                                                                                                                                                                         

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Bocchi (2008)[24](#jah31490-bib-0024){ref-type="ref"}                                                        Brazil                                                                                                                                                                                                                                                                                           20/41/26/12\                                                        50.7\                   Tx: 233\                     Y                         Mortality RR: 0.85\
                                                                                                                                                                                                                                                                                                                                                                                                                81% had LVEF ≤ 45%                                                  31%                     Co: 117                                                Readmission OR: 0.58

  Intervention:                                                                                                Disease management program including education and telephone monitoring                                                                                                                                                                                                                                                                                                                                                                             

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Bouvy (2003)[25](#jah31490-bib-0025){ref-type="ref"}                                                         Netherlands                                                                                                                                                                                                                                                                                      9/34/51/6\                                                          69.7\                   Tx: 74\                      NR                        Mortality RR: 0.67\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            34%                     Co: 78                                                 Readmission OR: NR

  Intervention:                                                                                                Pharmacists conducted structured interviews about medication use, reasons for nonadherence, and reinforcing adherence. Patients contacted monthly for follow‐up                                                                                                                                                                                                                                                                                     

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Capomolla (2002)[26](#jah31490-bib-0026){ref-type="ref"}                                                     Italy                                                                                                                                                                                                                                                                                            NYHA III to IV: 35%\                                                56\                     Tx: 112\                     NR                        Mortality RR: 0.16\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 29%                                                           16%                     Co: 122                                                Readmission OR: NR

  Intervention:                                                                                                Day‐hospital multidisciplinary HF management program including education, counseling, and nurse telephone follow‐up                                                                                                                                                                                                                                                                                                                                 

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Cleland (2005)[27](#jah31490-bib-0027){ref-type="ref"}                                                       UK, Germany, Netherlands                                                                                                                                                                                                                                                                         19.6/43.2/29.6/7.6\                                                 67.2\                   Tx A: 173\                   NR                        Mortality RR: 0.62\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 25%                                                           23%                     Tx B: 168\                                             Readmission OR: 0.80
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Co: 85                                                 

  Intervention:                                                                                                A: Nurse telephone support\                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                               B: Nurse telephone support plus home telemonitoring                                                                                                                                                                                                                                                                                                                                                                                                 

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Cline (1998)[28](#jah31490-bib-0028){ref-type="ref"}                                                         Sweden                                                                                                                                                                                                                                                                                           NR/NR/62/NR\                                                        75.6\                   Tx: 80\                      NR                        Mortality RR: 1.07\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 34%                                                           47%                     Co: 110                                                Readmission OR: 0.54

  Intervention:                                                                                                Patient and family disease and medication education, pill organizers, symptom diaries                                                                                                                                                                                                                                                                                                                                                               

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Dahl (2001)[29](#jah31490-bib-0029){ref-type="ref"}                                                          USA                                                                                                                                                                                                                                                                                              NR                                                                  73.5\                   Tx: 609\                     NR                        Mortality RR: 0.64\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    NR                      Co: 583                                                Readmission OR: 0.73

  Intervention:                                                                                                Advanced practice nurse delivered HF self‐care education to hospitalized patients. Follow‐up phone calls to high‐risk patients                                                                                                                                                                                                                                                                                                                      

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Dawson (1998)[30](#jah31490-bib-0030){ref-type="ref"}                                                        USA                                                                                                                                                                                                                                                                                              NR                                                                  70.6\                   Tx: 8\                       NR                        Mortality RR: NR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    50%                     Co: 2                                                  Readmission OR: 1.00

  Intervention:                                                                                                Advanced practice nurse conducted patient education and goal setting regarding HF pathophysiology, medications (effects and side effects), diet, exercise, symptom monitoring, and follow‐up appointments                                                                                                                                                                                                                                           

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  DeBusk (2004)[31](#jah31490-bib-0031){ref-type="ref"}                                                        USA                                                                                                                                                                                                                                                                                              I to II: 49%\                                                       72\                     Tx: 228\                     Y                         Mortality RR: 0.77\
                                                                                                                                                                                                                                                                                                                                                                                                                III to IV: 51%\                                                     49%                     Co: 234                                                Readmission OR: 1.04
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                                                                                                           

  Intervention:                                                                                                Home‐based nurse case management including patient education, self‐management skills, and care coordination                                                                                                                                                                                                                                                                                                                                         

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  DeWalt (2012)[32](#jah31490-bib-0032){ref-type="ref"}                                                        USA                                                                                                                                                                                                                                                                                              19/50/20/11\                                                        60.7\                   Tx: 303\                     Y                         Mortality RR: 0.68\
                                                                                                                                                                                                                                                                                                                                                                                                                59% had LVEF \<45%                                                  48%                     Co: 302                                                Readmission OR: NR

  Intervention:                                                                                                Single session of self‐care training, then telephone‐delivered self‐care training (5--8 calls over 4 weeks, then every 2 weeks, tapering to monthly) by health educators, including daily weights, symptom assessment, medication adherence, diuretic titration, low‐sodium diet, and exercise                                                                                                                                                      

  Control:                                                                                                     Single session of self‐care training plus usual care                                                                                                                                                                                                                                                                                                                                                                                                

  Doughty (2002)[33](#jah31490-bib-0033){ref-type="ref"}                                                       New Zealand                                                                                                                                                                                                                                                                                      0/0/24/76\                                                          73\                     Tx: 100\                     NR                        Mortality RR: 0.77\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 32%                                                           40.1%                   Co: 97                                                 Readmission OR: 1.18

  Intervention:                                                                                                Postdischarge clinical review, patient education, medication and weight diaries, and regular clinic follow‐up                                                                                                                                                                                                                                                                                                                                       

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Dunagan (2005)[34](#jah31490-bib-0034){ref-type="ref"}                                                       USA                                                                                                                                                                                                                                                                                              NR/20/71/9\                                                         70\                     Tx: 76\                      Y                         Mortality RR: 1.16\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            56%                     Co: 75                                                 Readmission OR: 0.70

  Intervention:                                                                                                Telephone monitoring by nurses including HF education, self‐management skills, diet, and adherence, plus screening for symptom changes and exacerbations                                                                                                                                                                                                                                                                                            

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Ekman (1998)[35](#jah31490-bib-0035){ref-type="ref"}                                                         Sweden                                                                                                                                                                                                                                                                                           NYHA III to IV: 100%\                                               80.3\                   Tx: 79\                      NR                        Mortality RR: 1.24\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 40.5%                                                         42%                     Co: 79                                                 Readmission OR: 0.88

  Intervention:                                                                                                Nurse‐monitored structured care program in an outpatient clinic including setting goals for medication adherence, weight, diet, or symptom monitoring                                                                                                                                                                                                                                                                                               

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Falces (2008)[36](#jah31490-bib-0036){ref-type="ref"}                                                        Spain                                                                                                                                                                                                                                                                                            II: 86%\                                                            79.5\                   Tx: 53\                      NR                        Mortality RR: 0.51\
                                                                                                                                                                                                                                                                                                                                                                                                                III to IV: 14%\                                                     58.3%                   Co: 50                                                 Readmission OR: 0.52
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 52%                                                                                                                                          

  Intervention:                                                                                                Education about HF, medication, and diet with telephone follow‐up                                                                                                                                                                                                                                                                                                                                                                                   

  Control:                                                                                                     Control type not specified                                                                                                                                                                                                                                                                                                                                                                                                                          

  Ferrante (2010)[37](#jah31490-bib-0037){ref-type="ref"}                                                      Argentina                                                                                                                                                                                                                                                                                        I to II: 50.6%\                                                     65\                     Tx: 760\                     NR                        Mortality RR: 1.06\
                                                                                                                                                                                                                                                                                                                                                                                                                III to IV: 49.4%\                                                   29.2%                   Co: 758                                                Readmission OR: 0.81
                                                                                                                                                                                                                                                                                                                                                                                                                79.6% had LVEF \<40%                                                                                                                               

  Intervention:                                                                                                Educational booklet and nurse‐delivered telephone education and monitoring focusing on improving adherence, exercise, symptom monitoring, weight, and edema                                                                                                                                                                                                                                                                                         

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Gattis (1999)[38](#jah31490-bib-0038){ref-type="ref"}                                                        USA                                                                                                                                                                                                                                                                                              13/54/30/3\                                                         67.3\                   Tx: 90\                      N                         Mortality RR: 0.59\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 30%[b](#jah31490-note-0003){ref-type="fn"}                    32%                     Co: 91                                                 Readmission OR: NR

  Intervention:                                                                                                Clinical pharmacist provided therapy optimization recommendations to physician and medication education to patients. Patients also received medication calendars and telephone follow‐up                                                                                                                                                                                                                                                            

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Harrison (2002)[39](#jah31490-bib-0039){ref-type="ref"}                                                      Canada                                                                                                                                                                                                                                                                                           1/22/67/10\                                                         75.6\                   Tx: 92\                      NR                        Mortality RR: 0.89\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            45%                     Co: 100                                                Readmission OR: 0.67

  Intervention:                                                                                                Transitional care intervention to provide education and closer monitoring at and after discharge from hospital                                                                                                                                                                                                                                                                                                                                      

  Control:                                                                                                     Usual care with similar number of provider contacts                                                                                                                                                                                                                                                                                                                                                                                                 

  Holland (2007)[40](#jah31490-bib-0040){ref-type="ref"}                                                       UK                                                                                                                                                                                                                                                                                               6/27/34/33\                                                         77\                     Tx: 149\                     NR                        Mortality RR: 1.20\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            53.5%                   Co: 144                                                Readmission OR: NR

  Intervention:                                                                                                Home visits by pharmacists to provide education on HF, self‐care, and medication. Medication organizers provided when deemed necessary                                                                                                                                                                                                                                                                                                              

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Jaarsma (1999)[41](#jah31490-bib-0041){ref-type="ref"}                                                       Netherlands                                                                                                                                                                                                                                                                                      III: 17%\                                                           73\                     Tx: 89\                      Y                         Mortality RR: 1.63\
                                                                                                                                                                                                                                                                                                                                                                                                                III to IV: 21%\                                                     42%                     Co: 97                                                 Readmission OR: 0.57
                                                                                                                                                                                                                                                                                                                                                                                                                IV: 61%\                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 34.4%                                                                                                                                        

  Intervention:                                                                                                HF education provided by a nurse, including symptom recognition, sodium restriction, fluid management, and adherence                                                                                                                                                                                                                                                                                                                                

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Jerant (2003)[42](#jah31490-bib-0042){ref-type="ref"}                                                        USA                                                                                                                                                                                                                                                                                              NR/65/32/3\                                                         70.1\                   Tx A: 13\                    N                         Mortality RR: 2.50\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            54%                     Tx B: 12\                                              Readmission OR: 0.49
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Co: 12                                                 

  Intervention:                                                                                                A: Home video‐based telecare visits\                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                               B: Telephone contact by a nurse                                                                                                                                                                                                                                                                                                                                                                                                                     

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Kasper (2002)[43](#jah31490-bib-0043){ref-type="ref"}                                                        USA                                                                                                                                                                                                                                                                                              NR/35.5/58.5/NR\                                                    62\                     Tx: 102\                     Y                         Mortality RR: 0.52\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 27.3%                                                         39.5%                   Co: 98                                                 Readmission OR: 0.62

  Intervention:                                                                                                Team‐based approach with algorithm‐based treatment plans with postdischarge clinic and telephone contacts, pill sorters, dietary support, and education                                                                                                                                                                                                                                                                                             

  Control:                                                                                                     Usual care by primary physicians                                                                                                                                                                                                                                                                                                                                                                                                                    

  Kimmelstiel (2004)[44](#jah31490-bib-0044){ref-type="ref"}                                                   USA                                                                                                                                                                                                                                                                                              1/54.5/42.5/2\                                                      72.1\                   Tx: 97\                      Y                         Mortality RR: 0.83\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 30.5%                                                         42%                     Co: 103                                                Readmission OR: 1.11

  Intervention:                                                                                                Home visit by a nurse focusing on medication adherence, barriers, and HF self‐care; written educational materials provided; telephone follow‐up                                                                                                                                                                                                                                                                                                     

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Koelling (2005)[45](#jah31490-bib-0045){ref-type="ref"}                                                      USA                                                                                                                                                                                                                                                                                              NYHA: NR\                                                           64.8\                   Tx: 107\                     NR                        Mortality RR: 0.76\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 26.5%                                                         42%                     Co: 116                                                Readmission OR: 0.45

  Intervention:                                                                                                Predischarge HF, self‐care, and medication education session with a nurse educator; patients given a copy of treatment guidelines in lay language                                                                                                                                                                                                                                                                                                   

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Krumholz (2002)[46](#jah31490-bib-0046){ref-type="ref"}                                                      USA                                                                                                                                                                                                                                                                                              NYHA: NR\                                                           73.8\                   Tx: 44\                      NR                        Mortality RR: 0.70\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 37.5%                                                         43%                     Co: 44                                                 Readmission OR: 0.41

  Intervention:                                                                                                HF patient education by nurse within 2 weeks of hospital discharge; telephone follow‐up for 12 months                                                                                                                                                                                                                                                                                                                                               

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Laramee (2003)[47](#jah31490-bib-0047){ref-type="ref"}                                                       USA                                                                                                                                                                                                                                                                                              17/45/35/3\                                                         70.7\                   Tx: 141\                     NR                        Mortality RR: 0.89\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            46%                     Co: 146                                                Readmission OR: 1.03

  Intervention:                                                                                                Inpatient care coordination by a nurse case manager; patient and family education; 12 weeks of telephone follow‐up; HF medications adjusted to optimal regimen per guidelines                                                                                                                                                                                                                                                                       

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Lopez‐Cabezas (2006)[48](#jah31490-bib-0048){ref-type="ref"}                                                 Spain                                                                                                                                                                                                                                                                                            I to II: 86%\                                                       75.7\                   Tx: 70\                      N                         Mortality RR: 0.43\
                                                                                                                                                                                                                                                                                                                                                                                                                III to IV: 14%\                                                     56%                     Co: 64                                                 Readmission OR: 0.50
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 51%                                                                                                                                          

  Intervention:                                                                                                Education about HF, diet, medications, and MA with telephone follow‐up                                                                                                                                                                                                                                                                                                                                                                              

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  McDonald (2002)[49](#jah31490-bib-0049){ref-type="ref"}                                                      Ireland                                                                                                                                                                                                                                                                                          NYHA: NR\                                                           70.8\                   Tx: 51\                      NR                        Mortality RR: 0.92\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 37%                                                           33.7%                   Co: 47                                                 Readmission OR: NR

  Intervention:                                                                                                Inpatient education consults by specialist nurse and dietician; postdischarge telephone follow‐up and HF clinic visits                                                                                                                                                                                                                                                                                                                              

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Mejhert (2004)[50](#jah31490-bib-0050){ref-type="ref"}                                                       Sweden                                                                                                                                                                                                                                                                                           NR/62/37/1\                                                         75.8\                   Tx: 103\                     NR                        Mortality RR: 1.20\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 34%                                                           42%                     Co: 105                                                Readmission OR: 1.06

  Intervention:                                                                                                Nurse‐monitored management program including symptom and laboratory monitoring, medication adjustment, and patient education; written educational materials                                                                                                                                                                                                                                                                                         

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Murray (2007)[51](#jah31490-bib-0051){ref-type="ref"}                                                        USA                                                                                                                                                                                                                                                                                              19.5/41/35/4.5\                                                     62.1\                   Tx: 122\                     Y                         Mortality RR: 1.50\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 49.6%                                                         66.9%                   Co: 192                                                Readmission OR: 0.82

  Intervention:                                                                                                Pharmacist‐delivered medication education, health literacy tools, and medication calendar; MA and weight monitoring                                                                                                                                                                                                                                                                                                                                 

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Nimpitakpong (2002)[52](#jah31490-bib-0052){ref-type="ref"}                                                  Thailand                                                                                                                                                                                                                                                                                         NR                                                                  61.4\                   Tx A: 38\                    NR                        Mortality RR: 1.71\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    47.5%                   Tx B: 42\                                              Readmission OR: 1.12
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Co: 45                                                 

  Intervention:                                                                                                A: Discharge consultation with a nurse; written materials with education, behavioral, and support strategies; consultation with a pharmacist\                                                                                                                                                                                                                                                                                                       
                                                                                                               B: All of elements of (A) plus follow‐up home visit for to monitor patient, problem solve, and reinforce MA                                                                                                                                                                                                                                                                                                                                         

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Nucifora (2006)[53](#jah31490-bib-0053){ref-type="ref"}                                                      Italy                                                                                                                                                                                                                                                                                            1/35/62/2\                                                          73\                     Tx: 99\                      NR                        Mortality RR: 1.79\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 43%                                                           38%                     Co: 101                                                Readmission OR: 1.00

  Intervention:                                                                                                Predischarge HF and treatment education by a cardiovascular nurse; telephone follow‐up; MA and symptoms assessment                                                                                                                                                                                                                                                                                                                                  

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Oddone (1999)[54](#jah31490-bib-0054){ref-type="ref"}                                                        USA                                                                                                                                                                                                                                                                                              11/36.5/33.5/19\                                                    64.5\                   Tx: 222\                     Y                         Mortality RR: 1.52\
                                                                                                                                                                                                                                                                                                                                                                                                                65% had LVEF \<40%                                                  1%                      Co: 221                                                Readmission OR: 1.62

  Intervention:                                                                                                Inpatient education provided by RN using AHA guidelines; Treatment plan developed with patient, physician, and nurse; postdischarge telephone and clinic follow‐up                                                                                                                                                                                                                                                                                  

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Powell (2010)[55](#jah31490-bib-0055){ref-type="ref"}                                                        USA                                                                                                                                                                                                                                                                                              III: 31.6%\                                                         63.6\                   Tx: 451\                     Y                         Mortality RR: 0.90\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            47.3%                   Co: 451                                                Readmission OR: 0.85

  Intervention:                                                                                                Group‐based self‐management counseling and skills training                                                                                                                                                                                                                                                                                                                                                                                          

  Control:                                                                                                     Usual care with HF education alone                                                                                                                                                                                                                                                                                                                                                                                                                  

  Rainville (1999)[56](#jah31490-bib-0056){ref-type="ref"}                                                     USA                                                                                                                                                                                                                                                                                              NR/14.7/67.7/17.7\                                                  69.9\                   Tx: 17\                      NR                        Mortality RR: NR\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            50%                     Co: 17                                                 Readmission OR: 0.22

  Intervention:                                                                                                Pharmacist and clinical nurse specialist identified and addressed patients' readmission risk factors; pharmacist‐delivered HF education, medication education; recommended medication changes                                                                                                                                                                                                                                                       

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Ramachandran (2007)[57](#jah31490-bib-0057){ref-type="ref"}                                                  India                                                                                                                                                                                                                                                                                            I to II: 74%\                                                       44.6\                   Tx: 25\                      NR                        Mortality RR: NR\
                                                                                                                                                                                                                                                                                                                                                                                                                III: 14%\                                                           22%                     Co: 25                                                 Readmission OR: 1.66
                                                                                                                                                                                                                                                                                                                                                                                                                IV: 12%\                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 21.8%                                                                                                                                        

  Intervention:                                                                                                Face‐to‐face and telephone HF self‐management education; patient education manual with self‐monitoring charts                                                                                                                                                                                                                                                                                                                                       

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Rich (1995)[58](#jah31490-bib-0058){ref-type="ref"}                                                          USA                                                                                                                                                                                                                                                                                              Mean NYHA class: 2.4\                                               79.3\                   Tx: 142\                     Y                         Mortality RR: 0.76\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 42%                                                           63%                     Co: 140                                                Readmission OR: 0.56

  Intervention:                                                                                                Inpatient HF education by a nurse, dietary and social service consultations; medication review by a geriatric cardiologist; postdischarge nurse follow‐up                                                                                                                                                                                                                                                                                           

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Riegel (2006)[59](#jah31490-bib-0059){ref-type="ref"}                                                        USA                                                                                                                                                                                                                                                                                              NR/18.7/46.3/35.1\                                                  72\                     Tx: 70\                      NR                        Mortality RR: 0.58\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 43.2%                                                         53.7%                   Co: 65                                                 Readmission OR: 0.97

  Intervention:                                                                                                Telephone nurse case management to teach self‐care knowledge and skills and monitor symptoms                                                                                                                                                                                                                                                                                                                                                        

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Ross (2004)[60](#jah31490-bib-0060){ref-type="ref"}                                                          USA                                                                                                                                                                                                                                                                                              NR                                                                  56\                     Tx: 54\                      NR                        Mortality RR: 0.98\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    23%                     Co: 53                                                 Readmission OR: 0.88

  Intervention:                                                                                                Web access to medical record, educational guide, and messaging system                                                                                                                                                                                                                                                                                                                                                                               

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Sadik (2005)[61](#jah31490-bib-0061){ref-type="ref"}                                                         UK                                                                                                                                                                                                                                                                                               29.5/50.5/16/4\                                                     58.7\                   Tx: 109\                     Y                         Mortality RR: 1.02\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            50%                     Co: 112                                                Readmission OR: NR

  Intervention:                                                                                                Regimen simplification (where possible); pharmacist‐provided HF, medication, and symptom management education; HF symptom and MA self‐monitoring                                                                                                                                                                                                                                                                                                    

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Sethares (2004)[62](#jah31490-bib-0062){ref-type="ref"}                                                      USA                                                                                                                                                                                                                                                                                              NR                                                                  76.2\                   Tx: 33\                      NR                        Mortality RR: NR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    100%                    Co: 37                                                 Readmission OR: 0.47

  Intervention:                                                                                                Tailored educational messages chosen based on responses to questions about treatment benefits and barriers                                                                                                                                                                                                                                                                                                                                          

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Shively (2013)[63](#jah31490-bib-0063){ref-type="ref"}                                                       USA                                                                                                                                                                                                                                                                                              3.6/33/52.4/NR\                                                     66.1\                   Tx: 43\                      NR                        Mortality RR: NR\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            1.2%                    Co: 41                                                 Readmission OR: 0.64

  Intervention:                                                                                                6‐month intervention delivered by advanced practice nurses; Content included goal setting, HF education, medication education, and barrier identification, symptom/weight monitoring, and planning responses to situations                                                                                                                                                                                                                          

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Sisk (2006)[64](#jah31490-bib-0064){ref-type="ref"}                                                          USA                                                                                                                                                                                                                                                                                              18.5/22.4/14/45.1\                                                  59.4\                   Tx: 203\                     Y                         Mortality RR: 1.00\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            46.3%                   Co: 203                                                Readmission OR: 0.77

  Intervention:                                                                                                Nurses counseled patients on HF self‐care, symptoms, and medications; care management team met to discuss patients regularly                                                                                                                                                                                                                                                                                                                        

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Stewart (2002)[65](#jah31490-bib-0065){ref-type="ref"}                                                       Australia                                                                                                                                                                                                                                                                                        NR/45.5/45/9.5\                                                     75\                     Tx: 149\                     Y                         Mortality RR: 0.86\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 38%                                                           43.8%                   Co: 148                                                Readmission OR: 0.75

  Intervention:                                                                                                Postdischarge home visit; review of patient\'s adherence to and knowledge of treatment; assessment of available social support and risk factors                                                                                                                                                                                                                                                                                                     

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Strömberg (2003)[66](#jah31490-bib-0066){ref-type="ref"}                                                     Sweden                                                                                                                                                                                                                                                                                           NR/18/71/11\                                                        77.5\                   Tx: 52\                      Y                         Mortality RR: 0.36\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            38.7%                   Co: 54                                                 Readmission OR: NR

  Intervention:                                                                                                Nurse‐led HF clinic; medications optimized, HF and social support education given; telephone follow‐up                                                                                                                                                                                                                                                                                                                                              

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Strömberg (2006)[67](#jah31490-bib-0067){ref-type="ref"}                                                     Sweden                                                                                                                                                                                                                                                                                           NR                                                                  70\                     Tx: 82\                      Y                         Mortality RR: 2.61\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    29.2%                   Co: 72                                                 Readmission OR: NR

  Intervention:                                                                                                7‐module computer‐based multimedia HF education program                                                                                                                                                                                                                                                                                                                                                                                             

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Tierney (2003)[68](#jah31490-bib-0068){ref-type="ref"}                                                       USA                                                                                                                                                                                                                                                                                              NR                                                                  60\                     Tx A: 197\                   Y                         Mortality RR: NR\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    66%                     Tx B: 158\                                             Readmission OR: 0.94
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Tx C: 170\                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Co: 181                                                

  Intervention:                                                                                                A: Automated guideline‐based care suggestions provided to physicians\                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                               B: Prompts to pharmacist to review guideline‐based cardiac care suggestions\                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                               C: Includes content of both treatments A and B                                                                                                                                                                                                                                                                                                                                                                                                      

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Tsuyuki (2004)[69](#jah31490-bib-0069){ref-type="ref"}                                                       Canada                                                                                                                                                                                                                                                                                           8/49/38/5\                                                          72\                     Tx: 140\                     NR                        Mortality RR: 1.30\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 31%                                                           42%                     Co: 136                                                Readmission OR: 1.21

  Intervention:                                                                                                Predischarge medication and HF education, adherence aids, written materials, and event diary provided; postdischarge follow‐up telephone contact for 6 months                                                                                                                                                                                                                                                                                       

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Udelson (2009)[70](#jah31490-bib-0070){ref-type="ref"}                                                       USA                                                                                                                                                                                                                                                                                              18.7/65.9/15.4/NR\                                                  65.3\                   Tx: 136\                     N                         Mortality RR: NR\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 29.5%                                                         26.2%                   Co: 133                                                Readmission OR: 1.04

  Intervention:                                                                                                Once‐daily dosing regimen                                                                                                                                                                                                                                                                                                                                                                                                                           

  Control:                                                                                                     Twice‐daily dosing regimen                                                                                                                                                                                                                                                                                                                                                                                                                          

  Varma (1999)[71](#jah31490-bib-0071){ref-type="ref"}                                                         UK                                                                                                                                                                                                                                                                                               Mean NYHA class: 2.12\                                              75.9\                   Tx: 42\                      NR                        Mortality RR: 0.98\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: NR                                                            59%                     Co: 41                                                 Readmission OR: NR

  Intervention:                                                                                                HF, medication, and symptom management education by a pharmacist; self‐monitoring diaries                                                                                                                                                                                                                                                                                                                                                           

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Wakefield (2009)[72](#jah31490-bib-0072){ref-type="ref"}                                                     USA                                                                                                                                                                                                                                                                                              NR/28/65/7\                                                         69.5\                   Tx A: 47\                    Y                         Mortality RR: 1.13\
                                                                                                                                                                                                                                                                                                                                                                                                                LVEF: 41.4%                                                         1%                      Tx B: 52\                                              Readmission OR: NR
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Co: 49                                                 

  Intervention:                                                                                                A: Telephone contacts for symptom monitoring and reinforcement of treatment plan by a nurse for 3 months postdischarge\                                                                                                                                                                                                                                                                                                                             
                                                                                                               B: Same as A, but using a videophone instead of telephone                                                                                                                                                                                                                                                                                                                                                                                           

  Control:                                                                                                     Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                          
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AHA indicates American Heart Association; HF, heart failure; LVEF, left ventricular ejection fraction; MA, medication adherence; NR, information not reported or not available; NYHA, New York Heart Association; OR, odds ratio; RN, registered nurse; RR, relative risk.

NYHA classification reported as percentage of subjects rated as class I/II/III/IV unless otherwise specified.

Median.

###### 

Descriptive Statistics of Eligible Studies

                                                           s    Min    Q~1~   Median   Q~3~   Max
  -------------------------------------------------------- ---- ------ ------ -------- ------ ------
  Year of publication                                      57   1996   2002   2004     2007   2013
  Mean age (y)                                             56   44.6   64.9   70.4     75     80.3
  Total post‐test sample size per study                    57   10     107    197      306    3902
  Percentage attrition                                     57   0      0      0        0      9.5
  Percentage female                                        55   1      32.4   42       50     100
  Percentage from under‐represented racial/ethnic groups   23   4.5    19     26.5     54     100

s=number of studies.

Interventions in the Reviewed Studies {#jah31490-sec-0012}
-------------------------------------

Intervention descriptions across the eligible studies varied widely in degree of detail. A bulk of the interventions utilized medication education (s=50) and disease education (s=48) as components of their interventions. In addition to using educational approaches, 14 interventions improved integration of care for HF patients and 11 attempted to get patients to incorporate self‐management strategies in some manner. Another common intervention strategy was self‐monitoring. Eight interventions had patients self‐monitor their medication‐taking behavior by using a medication diary or other means, whereas 28 interventions encouraged patient self‐monitoring of HF signs or symptoms. All but 4 interventions used multiple intervention strategies to improve adherence. The single‐strategy approaches involved disease education (s=2), dose modification (s=1), and a patient web portal (s=1). Although most studies used medication education in combination with other strategies, no other distinct patterns of intervention component combinations emerged.

Fifty‐two interventions involved some degree of face‐to‐face contact with an interventionist. Many interventions involved interventionists from more than 1 discipline. Of those that specified the interventionist profession, 40 used nurses (including 5 using advanced practice nurses), 14 used pharmacists, 15 used physicians, 7 had dieticians, 6 had social workers, 1 had a case manager, and 4 employed unspecified health care providers. Only 4 studies had interventions delivered by the patients' regular health care providers.

Information about intervention dose was poorly reported across the studies. Only 28 studies clearly reported the number of intervention sessions (median=6.5 sessions; range, 1--52). Six studies reported the number of minutes per session (median=48.75; range, 10--120). Interventions were delivered over a median of 181 days (s=48; range, 1--901).

Nearly all interventions incorporated some form of verbal interaction in which interventionists talked to patients about their HF or HF medication. Thirty‐eight interventions were delivered partly over the telephone. Fewer used telehealth (s=2), text messaging (s=2), computer delivery (s=4), video (s=6), or mailed intervention materials (s=4).

Meta‐Analysis of Study Outcomes {#jah31490-sec-0013}
-------------------------------

Forty‐eight studies reported sufficient data for calculating mortality outcome ESs (see Figure [4](#jah31490-fig-0004){ref-type="fig"}). Random‐effects meta‐analysis found that mortality risk was 10.6% lower among HF patients who received MA interventions when compared to control groups (RR, 0.89; 95% CI, 0.81, 0.99). The pooled analysis yielded low, but significant, heterogeneity, with a *Q*‐statistic of 67.46 (*P*=0.027) and an *I* ^2^ of 30.33. When 2 studies with significant residuals were removed to test for potential outliers, RR was essentially unchanged (RR, 0.92; 95% CI, 0.85, 1.00), but the heterogeneity was reduced (*Q*=52.88; *P*=0.196; *I* ^2^=14.90).

![Forest plot for mortality outcome. RR indicates relative risk.](JAH3-5-e002606-g004){#jah31490-fig-0004}

MA interventions also reduced HF patients' risk of hospitalization (RR=0.89; 95% CI, 0.81, 0.97). However, only 32 treatment versus control studies contributed to the pooled estimate of RR. In order to include a larger number of studies in the hospitalization meta‐analysis, we used the OR metric because 43 studies could provide data for the calculation of the overall effect (see Figure [5](#jah31490-fig-0005){ref-type="fig"}). The pooled random‐effects OR was 0.79 (95% CI, 0.71, 0.89). Again, the studies contained significant heterogeneity (*Q*=72.00; *P*=0.003; *I* ^2^=41.66). In this analysis, 2 studies had significant residuals. Removing those studies from the analysis gave an OR of 0.79 (95% CI, 0.73, 0.87) and reduced heterogeneity (*Q*=44.54; *P*=0.287; *I* ^2^=10.19). Pooled analysis statistics for both mortality and hospitalization outcomes are reported in Table [4](#jah31490-tbl-0004){ref-type="table-wrap"}.

![Forest plot for readmissions outcome. OR indicates odds ratio.](JAH3-5-e002606-g005){#jah31490-fig-0005}

###### 

Meta‐Analysis Summary Statistics

  Outcome        Relative Risk   Odds Ratio                                     *Q*          *I* ^2^                                                                                                                     
  -------------- --------------- ---------------------------------------------- ------------ --------- -------------------------------------------------- ------------ ------------------------------------------------- -------
  Mortality      48              0.89[\*](#jah31490-note-0006){ref-type="fn"}   0.81, 0.99   48        0.86[\*](#jah31490-note-0006){ref-type="fn"}       0.76, 0.98   67.46[\*](#jah31490-note-0006){ref-type="fn"}     30.33
  Readmissions   32              0.89[\*](#jah31490-note-0006){ref-type="fn"}   0.81, 0.97   43        0.79[\*\*\*](#jah31490-note-0006){ref-type="fn"}   0.71, 0.89   72.00[\*\*](#jah31490-note-0006){ref-type="fn"}   41.66

*I* ^2^ indicates heterogeneity index; *k*, number of comparisons; *Q*, heterogeneity statistic.

\**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.001.

Risk of Bias Sensitivity Analyses {#jah31490-sec-0014}
---------------------------------

We conducted moderator analyses to evaluate whether ESs were different based on factors such as year of publication, presence of funding, study location, type of control group, randomization procedures, blinding, and use of intent‐to‐treat analyses (see Table [5](#jah31490-tbl-0005){ref-type="table-wrap"} for list of report and methodological moderators analyzed). No significant ES differences were detected from any of the risk of bias analyses for either mortality or hospitalization outcomes.

###### 

List of Tested Moderators

  ------------------------------------------------------------
  Report and methodological moderators
  Allocation concealment
  Blinding of data collectors
  Location where study was conducted
  Presence of funding
  Publication method (eg, journal article, dissertation)
  Randomization method
  Type of control group (true control vs attention‐control)
  Use of intent‐to‐treat analyses
  Year of publication
  Sample moderators
  Sex (% of women in sample)
  Mean sample age
  Presence of comorbidities
  Race/ethnicity
  Intervention moderators
  Disease education
  Dose modification
  Duration of intervention
  Goal setting
  Improving health care provider skills to address adherence
  Improved integration of health care services
  Increasing health care providers' time with patients
  Institutional system change
  Mediated intervention
  Computer‐mediated intervention
  Telephone‐mediated intervention
  Medication education/counseling
  No. of intervention sessions
  Problem solving
  Review of medications for appropriateness
  Self‐management skills
  Self‐monitoring of medication
  Self‐monitoring of signs or symptoms of heart failure
  Social support
  Type of interventionist
  Written materials to improve adherence
  ------------------------------------------------------------

Intervention and Sample Moderators {#jah31490-sec-0015}
----------------------------------

Although the studies tested many different types of interventions, only 2 intervention components showed significant ES differences in our moderator analyses (Table [6](#jah31490-tbl-0006){ref-type="table-wrap"}). For mortality outcomes, interventions that included components to improve health care providers' skills for addressing MA with their patients had a greater risk for mortality than did interventions not trying to improve health care provider adherence skills (RR, 1.50 vs 0.87; *P*=0.007). However, because only 4 studies' interventions included content to improve health care providers' adherence management skills, this finding must be interpreted carefully.

###### 

Selected Intervention Moderators for Mortality and Readmission Outcomes

  Moderator                                                                          *k*   RR      95% CI       *I* ^*2*^, %   *Q*    *P* Value
  ---------------------------------------------------------------------------------- ----- ------- ------------ -------------- ------ -----------
  Mortality                                                                                                                           
  Intervention included disease education                                                                                             
  Yes                                                                                42    0.91    0.82, 1.01   32.35          2.59   0.107
  No                                                                                 6     0.72    0.55, 0.94   0.00                  
  Intervention included medication education                                                                                          
  Yes                                                                                41    0.89    0.81, 0.98   26.28          0.00   0.995
  No                                                                                 7     0.89    0.57, 1.41   54.49                 
  Intervention designed to improve health care providers' skills for addressing MA                                                    
  Yes                                                                                4     1.50    1.02, 2.19   0.00           7.34   0.007
  No                                                                                 44    0.87    0.79, 0.96   29.39                 
  Intervention included patient self‐monitoring of medication‐taking                                                                  
  Yes                                                                                7     0.93    0.73, 1.18   0.00           0.14   0.711
  No                                                                                 41    0.89    0.79, 0.99   38.68                 
  Readmissions                                                                                                                        
  Intervention included disease education                                                                                             
  Yes                                                                                38    0.81    0.73, 0.90   35.21          0.80   0.372
  No                                                                                 5     0.58    0.29, 1.18   72.24                 
  Intervention included medication education                                                                                          
  Yes                                                                                38    0.81    0.73, 0.90   33.55          1.15   0.283
  No                                                                                 5     0.57    0.30, 1.08   73.03                 
  Intervention designed to improve health care providers' skills for addressing MA                                                    
  Yes                                                                                4     0.99    0.76, 1.27   0.00           2.86   0.091
  No                                                                                 39    0.772   0.69, 0.87   44.25                 
  Self‐monitoring of medication taking                                                                                                
  Yes                                                                                6     1.03    0.83, 1.28   0.00           5.81   0.016
  No                                                                                 37    0.76    0.68, 0.86   42.38                 

*k* indicates the number of comparisons; MA, medication adherence; OR, odds ratio; RR, relative risk.

For hospitalization outcomes, interventions that did not include self‐monitoring of patients' medication taking had a lower mean OR than did interventions using self‐monitoring (OR, 0.76 vs 1.03; *P*=0.016). Other intervention components as well as sample moderators, such as sex, age, and race/ethnicity, were tested for their influence on ES (see Table [5](#jah31490-tbl-0005){ref-type="table-wrap"}), but no significant differences were found.

Discussion {#jah31490-sec-0016}
==========

Our analyses found that interventions to improve adherence to medications for HF significantly reduce the risk for both hospitalization and death. The ESs for these outcomes were largely consistent across studies, with little heterogeneity in the overall ES estimates. In performing this analysis, we conducted a comprehensive search to include a broad spectrum of intervention studies. Previous meta‐analyses of HF management programs have been more restricted in focus, examining distance‐mediated interventions using telephone support or telemonitoring[73](#jah31490-bib-0073){ref-type="ref"} or outpatient disease management programs.[74](#jah31490-bib-0074){ref-type="ref"} Another meta‐analysis by Feltner et al.[75](#jah31490-bib-0075){ref-type="ref"} examined transitional care interventions to prevent HF readmissions, but did not report overall ES estimates across intervention types.

Comparison With Past Meta‐Analyses {#jah31490-sec-0017}
----------------------------------

ESs in this meta‐analysis are largely consistent with ESs in previous meta‐analyses reporting results across far fewer primary studies. For mortality, our RR of 0.89 was lower than Gwadry‐Sridhar et al.\'s[76](#jah31490-bib-0076){ref-type="ref"} finding of 0.98 and similar to Inglis et al.\'s[73](#jah31490-bib-0073){ref-type="ref"} findings for structured telephone support interventions (RR=0.88). The RR of mortality we calculated is somewhat greater than what Inglis et al. found for telemonitoring interventions (RR=0.66).[73](#jah31490-bib-0073){ref-type="ref"} In their meta‐analysis of HF care management programs, Wakefield et al.[74](#jah31490-bib-0074){ref-type="ref"} found a mortality outcome OR of 0.79 (converted from the reported standardized mean difference \[*d*\]), which is comparable to our mortality OR of 0.86.

Looking at readmission outcomes, we found an OR of 0.79 and RR of 0.89. Wakefield et al. identified an OR of 0.75 (converted from *d*),[74](#jah31490-bib-0074){ref-type="ref"} whereas Gwadry‐Sridhar et al. reported a RR of 0.79[76](#jah31490-bib-0076){ref-type="ref"} and Inglis et al. reported RRs of 0.92 and 0.91 for structured telephone support and telemonitoring interventions, respectively.[73](#jah31490-bib-0073){ref-type="ref"}

Previous meta‐analyses did not conduct moderator analyses to determine which intervention components were associated with larger ESs. In our project, we found that readmission outcomes were actually better when adherence interventions did not have patients self‐monitoring their medication‐taking behavior. A previous meta‐analysis looking at adherence interventions among older adults found that self‐monitoring interventions were associated with increased MA ESs.[77](#jah31490-bib-0077){ref-type="ref"} It is possible that for HF patients, self‐monitoring of disease symptoms, such as daily weight measurement, may be more useful than monitoring medication taking to prevent hospital readmission.

An interesting finding in this project was that interventions designed to train health care providers to have better skills for addressing MA actually resulted in a greater mortality risk for patients than did interventions not focusing on health care providers. This finding must be interpreted cautiously, given that only 4 studies included improving health care providers' skills for addressing adherence. Each of these 4 interventions also included a variety of other types of intervention components. Whereas health care provider skills and health care system interventions are important, interventions to improve MA must be patient centered. It is very difficult to modify patient behavior simply by modifying health care provider behavior, and a broader meta‐analysis of health care provider interventions to improve MA found that whereas health care provider interventions are modestly effective, interventions must also include patient‐centered approaches.[78](#jah31490-bib-0078){ref-type="ref"}

Limitations {#jah31490-sec-0018}
-----------

Any meta‐analysis project is subject to certain limitations. First, it is always possible that some eligible studies may have not been identified through our searches. We used comprehensive search methods to identify as many eligible studies as possible and employed careful study‐tracking procedures to avoid excluding any eligible studies. Meta‐analyses are limited, however, by the primary research that has been conducted, methodological quality of the primary research, and quality of reporting of the primary studies. It is unknown whether otherwise eligible studies that were excluded because of inadequate data for calculating ESs might have impacted the overall ES.

Recommendations for Future Research {#jah31490-sec-0019}
-----------------------------------

Room exists to develop interventions that further improve mortality and readmission risk for HF patients. Many MA interventions for HF patients are conducted as part of broader HF self‐care interventions. No quantitative synthesis has yet summarized and compared effectiveness across HF self‐care interventions to identify the most effective approach to improve HF outcomes. Furthermore, it is likely that the most effective approaches may differ for specific patient populations, a research question that may be further explored through meta‐analysis.

The lack of heterogeneity in mortality and readmission outcomes indicates that any intervention that successfully improves HF medication adherence is likely to improve mortality and readmission outcomes. Future research should investigate methods to assess adherence in clinical practice settings and integrate MA interventions into practice to improve clinical outcomes, and whether any type of additional attention may improve HF mortality and readmission rates.

Conclusion {#jah31490-sec-0020}
==========

Overall, interventions to improve adherence to HF medications lower risk for hospital readmission and overall mortality. MA is a key component of HF self‐care and should be addressed as part of any HF self‐care program. Room may exist for further improving MA interventions for HF patients, but the existing data show that the standard of care for addressing adherence in clinical practice can be improved to reduce HF morbidity and mortality.
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